Kornea Neovaskülarizasyonunun Ranibizumab (Lucentis) ile Baskılanması: Tavşan Korneasında Deneysel Çalışma
نویسندگان
چکیده
The purpose of this study was to evaluate the effects of the use of the subconjunctival injection of ranibizumab (Lucentis) on angiogenesis in the rabbit cornea. Corneas of 12 New Zealand Rabbits were cauterized with silver nitrate crystal. Animals were divided in two groups: control group (GC) that received 0.02 ml of 0.9% saline solution; group ranibizumab (GR) that received 0.5 mg of ranibizumab subconjunctivally at the 24th h after the lesion was formed. Animals corneas were extracted on the 14th day under general anesthesia. The newly formed vessels digital photographs were obtained and analyzed in a computerized system (google sketch-up program). In the control group, neovascularization covered 64.66%±20.81 (mean±standard deviation [SD]) of the corneal surface, compared with 34.17%±4.53 (mean±SD) in the GR group. When vascular density is compared between treated groups, statistical differences were observed (P<0.002). The results showed an inhibition of angiogenesis when the control group was compared with ranibizumab treated groups. These results suggest that subconjunctival injection of ranibizumab is able to inhibit corneal angiogenesis.
منابع مشابه
A case of subacute cutaneous lupus erythematosus as a result of ranibizumab (Lucentis) treatment
Cutaneous lupus erythematosus is a previously undiagnosed side-effect of ranibizumab. Here, we present a case of an 82-year-old female Caucasian patient with wet age-related macular degeneration. Following a single intraocular injection of Lucentis (ranibizumab), she developed a subacute cutaneous lupus erythematosus which, with treatment, took nearly 12 months to resolve. This shows that cutan...
متن کاملİmmün baskılanması olan hastaların aşılanması Vaccination in patients with immunosuppression Davetli Derleme / Invited Review
sonrası hücresel/hümoral immün sistemin baskılanması) immün sistem baskılanması olan hastalarda aşı ile önlenebilir hastalıklara yakalanma ve hastalığı ağır geçirme olasılığı yüksektir. İmmün yetersizliği olan hastalarda aşıların güvenlik ve etkililiği immün baskılanma yapısı ve ağırlığına göre değişkenlik göstermektedir. Günümüzde immün yetersizlik durumlarında aşıların etkinlik ve güvenliği i...
متن کاملIncidence of Intraocular Pressure Elevation following Intravitreal Ranibizumab (Lucentis) for Age-related Macular Degeneration
AIM The aim of this article is to evaluate the rate of patients developing sustained elevated intraocular pressure (IOP) after ranibizumab (Lucentis) intravitreal (IVT) injections. DESIGN This is a retrospective study. PARTICIPANTS Charts of 192 consecutive patients receiving Lucentis for age-related macular degeneration (AMD) were retrospectively reviewed. MATERIALS AND METHODS We enroll...
متن کاملComplete Resolution of a Giant Pigment Epithelial Detachment Secondary to Exudative Age-Related Macular Degeneration after a Single Intravitreal Ranibizumab (Lucentis) Injection: Results Documented by Optical Coherence Tomography
AIM To describe a patient with a giant pigment epithelial detachment (PED) secondary to exudative age-related macular degeneration (ARMD) successfully treated with a single intravitreal ranibizumab (Lucentis) injection (0.5 mg/0.05 ml). METHODS An 89-year-old woman presented with a six-day history of reduced vision and distortion in the left eye. Best-corrected visual acuity in that eye was 6...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2011